- Consumer Products
- Latest 8.13
- Currency US$
- Change -0.24
- Percent Change -2.867 %
- Volume 20,490
- Fri Mar 7, 2014 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 25||$-0.46||May 6||$-0.32|
12 months ended Mar 10, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.